|
Provider Newsletter- Naloxone Standing Order 199.91 KB |
|
2023/09/26 |
|
Pharmacy Newsletter- Test strip limits with CGM 226.9 KB |
|
2023/09/08 |
|
Provider Newsletter July 2023 PDL Update 265.14 KB |
|
2023/08/15 |
|
Pharmacy Newsletter: Buprenorphine Monotherapy 184.89 KB |
|
2023/05/19 |
|
Pharmacy Newsletter- Public Health Emergency Termination 246.79 KB |
|
2023/05/08 |
|
Provider Newsletter DEL Update 209.98 KB |
|
2023/05/08 |
|
Provider Newsletter April 2023 PDL Update 260.56 KB |
|
2023/04/14 |
|
End of RSV Season palivizumab Coverage 2023 122.81 KB |
|
2023/03/03 |
|
Pharmacy Newsletter 2023 195 KB |
|
2023/03/03 |
|
Provider Newsletter February 2023 PDL Update 243.99 KB |
|
2023/02/06 |
|
Pharmacy Benefit Update Winter 2022 224.31 KB |
PDL Changes will be effective January 1, 2023 |
2022/12/12 |
|
Influenza 2022_2023 212.4 KB |
|
2022/10/25 |
|
Provider Newsletter October 7 2022 PDL Update 176.13 KB |
|
2022/10/07 |
|
ProAir HFA Discontinuation 163.97 KB |
|
2022/10/07 |
|
PartD Copay and Plan Changes Effective 1/1/23 162.19 KB |
|
2022/10/07 |
|
Provider Newsletter August 2 2022 PDL Update 142.99 KB |
|
2022/08/02 |
|
Requiring Prescriber Enrollment 111.96 KB |
|
2022/06/20 |
|
Provider Newsletter April 8 2022 PDL Update 145.61 KB |
|
2022/04/11 |
|
End of Atypical Inter-Season palivizumab coverage 119.4 KB |
|
2022/03/08 |
|
Pharmacy Updates: Varenicline and NPH Newsletter 179.14 KB |
|
2022/02/24 |
|
REMINDER: Standing Order for Dispensing COVID OTC Test Kit 155.78 KB |
|
2022/02/07 |
|
Provider Newsletter January 14 2022 PDL Update 166.28 KB |
|
2022/01/14 |
|
Buprenorphine Pregnancy Memo 94.39 KB |
|
2022/01/13 |